Sepsis - Nursing Case Study
Pathophysiology
• Primary mechanism: Sepsis initiates with a dysregulated host response to infection, leading to widespread inflammation. This is marked by excessive cytokine release, known as a "cytokine storm," which disrupts normal immune function and promotes systemic damage.
• Secondary mechanism: The inflammatory cascade causes endothelial dysfunction, resulting in increased vascular permeability and vasodilation. This leads to hypotension and impaired tissue perfusion, which can progress to multi-organ dysfunction.
• Key complication: Persistent hypotension despite fluid resuscitation, known as septic shock, is a critical complication. It results in severe tissue hypoxia and metabolic acidosis, further exacerbating organ failure and increasing mortality risk.
Patient Profile
Demographics:
67-year-old male, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 3
• Current medications: Lisinopril, Metformin, Atorvastatin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Fever and confusion
• Key symptoms: Shivering, rapid breathing, decreased urine output, generalized weakness
• Vital signs: Temperature 39.2°C (102.6°F), Heart rate 110 bpm, Respiratory rate 24 breaths/min, Blood pressure 92/60 mmHg, SpO2 90% on room air
Section 1
The initial assessment reveals that the patient is experiencing increasing confusion, which suggests a worsening of his neurological status. Neurologically, he is disoriented to time and place, with a Glasgow Coma Scale (GCS) score of 13. Cardiovascular assessment shows cool, mottled extremities, indicating peripheral vasoconstriction and inadequate perfusion. Auscultation of the lungs reveals diminished breath sounds bilaterally, with crackles at the bases, suggesting potential pulmonary involvement. This is consistent with fluid accumulation, possibly secondary to acute respiratory distress syndrome (ARDS), a known complication of severe sepsis. His urine output has continued to decline to less than 20 mL/hr, raising concerns of acute kidney injury superimposed on his chronic kidney disease.
Laboratory results reveal further derangements: the patient's white blood cell count is elevated at 18,000/µL, indicating a persistent inflammatory response. His lactate level is elevated at 4.5 mmol/L, reflecting ongoing tissue hypoperfusion and metabolic acidosis. Blood cultures have returned positive for gram-negative bacilli, confirming a bacterial source of infection. Renal function tests show an increased creatinine level of 2.5 mg/dL from a baseline of 1.8 mg/dL, and his blood urea nitrogen (BUN) is also elevated at 45 mg/dL, corroborating the development of acute kidney injury. Arterial blood gas analysis shows a pH of 7.28, PaCO2 of 32 mmHg, and HCO3- of 15 mEq/L, indicating a mixed metabolic and respiratory acidosis.
In response to these findings, the healthcare team intensifies the patient's management. Despite initial fluid resuscitation, his blood pressure remains low, necessitating the initiation of vasopressor support with norepinephrine to maintain mean arterial pressure (MAP) above 65 mmHg. Given the positive blood cultures for gram-negative bacteria, broad-spectrum antibiotics are adjusted to target the identified pathogen specifically. Continuous monitoring of urine output and renal function is prioritized, with plans for potential renal replacement therapy if oliguria and azotemia persist. The patient is closely monitored for signs of further deterioration or the emergence of additional complications, such as disseminated intravascular coagulation or worsening respiratory failure, which would require escalation of care.
Section 2
As the patient's condition evolves, new complications emerge, prompting further clinical assessment and decision-making. Over the next 12 hours, the patient exhibits signs of worsening respiratory status. His respiratory rate increases to 32 breaths per minute, and he becomes more tachypneic, struggling to maintain adequate oxygen saturation despite supplemental oxygen. Arterial blood gas analysis reveals a PaO2 of 60 mmHg on 60% FiO2, indicating severe hypoxemia. The diminished breath sounds and bilateral crackles noted earlier have progressed, suggestive of escalating pulmonary edema and potential progression to acute respiratory distress syndrome (ARDS). The healthcare team decides to escalate respiratory support, considering options such as non-invasive ventilation or mechanical ventilation to improve oxygenation and reduce the work of breathing.
Concurrently, the patient's renal function continues to decline. Despite aggressive fluid management and norepinephrine support, urine output remains critically low, averaging less than 15 mL/hr, accompanied by worsening azotemia with a creatinine level now at 3.0 mg/dL and BUN at 60 mg/dL. Electrolyte imbalances also start to emerge, with hyperkalemia noted at 5.8 mEq/L. Given these developments, the nephrology team is consulted, and plans are made to initiate renal replacement therapy to address the acute kidney injury and prevent further metabolic derangements.
Throughout these developments, the patient's vital signs show a persistent requirement for vasopressor support, with MAP hovering just above 65 mmHg. The cardiovascular assessment indicates no significant improvement in peripheral perfusion, with extremities remaining cool and mottled. The healthcare team remains vigilant for any signs of disseminated intravascular coagulation, given the risk associated with severe sepsis and ongoing inflammatory response marked by elevated white blood cell count and lactate levels. Continuous monitoring and reassessment are crucial as the team navigates these complex, interwoven challenges, aiming to stabilize the patient and prevent further deterioration.
Section 3
As the patient's condition progresses, new diagnostic results reveal additional complications. A repeat chest X-ray shows worsening bilateral infiltrates, consistent with the progression to acute respiratory distress syndrome (ARDS). This finding aligns with the patient's increasing respiratory distress and hypoxemia, despite high-flow supplemental oxygen. The healthcare team decides to proceed with mechanical ventilation to improve oxygenation and decrease the work of breathing. Careful consideration is given to the ventilation strategy, emphasizing low tidal volumes and adequate positive end-expiratory pressure (PEEP) to prevent further lung injury.
Concurrently, laboratory results indicate a further deterioration in the patient's hematological status. A complete blood count shows a drop in platelet count to 90,000/mm³, raising concerns for the onset of disseminated intravascular coagulation (DIC). Coagulation studies reveal an elevated D-dimer and prolonged prothrombin time, supporting this suspicion. The team initiates close monitoring for bleeding tendencies and prepares to administer appropriate blood products if necessary. The patient's condition is further complicated by new electrolyte imbalances, particularly hypocalcemia with a calcium level of 7.8 mg/dL, potentially contributing to neuromuscular irritability and requiring correction.
Despite these challenges, there are some positive responses to the interventions. After initiating renal replacement therapy, the patient's hyperkalemia gradually resolves, and urine output begins to improve slightly, suggesting a potential stabilization of renal function. Continuous reassessment and timely interventions remain crucial as the team works to stabilize the patient, addressing each complication systematically while maintaining a holistic view of his critical condition. The focus remains on balancing aggressive treatment with supportive care to optimize outcomes and prevent further deterioration.
Section 4
As the patient's care continues, new diagnostic results reveal further complications. A repeat ultrasound of the abdomen is performed to evaluate the patient's liver function and possible contributing factors to his coagulopathy. The ultrasound shows hepatomegaly and mild ascites, with laboratory tests indicating elevated liver enzymes: AST at 150 U/L and ALT at 180 U/L. These findings suggest the development of acute liver dysfunction, potentially secondary to the systemic inflammatory response and the ongoing sepsis. This liver impairment may be contributing to the observed coagulopathy and necessitates an adjustment in the management plan.
Additionally, the patient's neurological status becomes a focal point for further assessment. Despite the mechanical ventilation and ongoing sedation, nursing staff note episodes of increased agitation and tremors, correlating with the hypocalcemia. Neurological assessment reveals diminished deep tendon reflexes and intermittent muscle twitching, consistent with electrolyte imbalance. Calcium gluconate is administered intravenously to address the hypocalcemia, with the aim of stabilizing neuromuscular function and preventing further neurological compromise.
The healthcare team remains vigilant, recognizing that the patient's multi-organ involvement requires a coordinated and dynamic approach. The team prioritizes a comprehensive care plan that addresses not only the primary issues of sepsis and ARDS but also the secondary complications such as liver dysfunction and electrolyte imbalances. This approach ensures that each aspect of the patient's condition is managed systematically while supporting the overall goal of stabilization and recovery. As the team implements these targeted interventions, they prepare for the possibility of additional complications, maintaining readiness to adapt the treatment strategy as needed.
Section 5
As the care team continues to monitor the patient's condition, a change in patient status becomes evident. The patient's blood pressure, previously stable under vasopressor support, begins to trend downward with readings consistently below the target mean arterial pressure (MAP) of 65 mmHg, despite adjustments in medication dosages. Concurrently, the heart rate escalates to 120 beats per minute, suggesting a compensatory response to maintain perfusion. The patient also exhibits signs of worsening respiratory distress, with increased oxygen requirements and a rising PaCO2 level on arterial blood gases, indicating potential respiratory fatigue or worsening pulmonary function.
In response to these developments, the team orders additional diagnostic tests, including a repeat lactate level, which now shows a concerning increase to 5.0 mmol/L, indicative of worsening tissue hypoperfusion and possible progression into septic shock. This biochemical marker, along with the hemodynamic instability, prompts the team to intensify their resuscitation efforts. The patient receives an increased fluid bolus and further titration of vasopressors, aiming to enhance cardiac output and improve tissue oxygenation.
Despite these interventions, the patient's urine output remains significantly decreased, raising concerns about acute kidney injury (AKI) secondary to sepsis and hypotension. The nephrology team is consulted to evaluate the need for renal replacement therapy as part of the evolving management plan. The team remains vigilant, aware that these complications necessitate a fine balance between aggressive treatment and the prevention of fluid overload, particularly given the patient's compromised respiratory status. With these developments, the healthcare team prepares for potential escalation of care, considering the need for additional supportive measures as they strive for patient stabilization and recovery.